tiprankstipranks
Minerva Neurosciences (NERV)
NASDAQ:NERV

Minerva Neurosciences (NERV) Financial Statements

556 Followers

Minerva Neurosciences Financial Overview

Minerva Neurosciences's market cap is currently ―. The company's EPS TTM is $-4.654; its P/E ratio is -0.54; Minerva Neurosciences is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-1.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.83M$ -5.74M$ -4.16M$ -4.99M$ -5.10M
EBITDA$ -6.82M$ -5.73M$ 0.00$ -4.99M$ -5.09M
Net Income Common Stockholders$ -9.02M$ -7.82M$ -6.19M$ -6.97M$ -6.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 40.91M$ 46.90M$ 51.90M$ 36.08M$ 36.19M
Total Assets$ 56.90M$ 63.13M$ 67.14M$ 51.59M$ 55.09M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -40.91M$ -46.90M$ -51.90M$ -36.08M$ -36.19M
Total Liabilities$ 85.36M$ 83.18M$ 79.65M$ 78.21M$ 75.11M
Stockholders Equity$ -28.46M$ -20.05M$ -12.54M$ -26.64M$ -20.02M
Cash Flow-
Free Cash Flow$ -6.00M$ -4.80M-$ 100.00K-
Operating Cash Flow$ -6.00M$ -4.80M-$ 100.00K-
Investing Cash Flow-----
Financing Cash Flow-$ -86.69K---
Currency in USD

Minerva Neurosciences Earnings and Revenue History

Minerva Neurosciences Debt to Assets

Minerva Neurosciences Cash Flow

Minerva Neurosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis